Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 41 to 41 of 41

Publication Record


Differences in response in vivo to amphotericin B among Candida albicans strains.
O'Day DM, Ray WA, Robinson RD, Head WS, Williams TE
(1991) Invest Ophthalmol Vis Sci 32: 1569-72
MeSH Terms: Administration, Topical, Amphotericin B, Animals, Candida albicans, Candidiasis, Colony Count, Microbial, Cornea, Dose-Response Relationship, Drug, Drug Resistance, Microbial, Eye Infections, Fungal, Humans, Keratitis, Rabbits
Show Abstract · Added March 5, 2014
A group of ten Candida albicans strains previously determined to be resistant or susceptible to topical amphotericin B in vivo and in vitro were exposed to treatment with different concentrations of the drug in a quantitative model of candidal keratitis in Dutch-belted rabbits. After 5 days of topical treatment with amphotericin B eye drops in concentrations of 0.3%, 0.03%, or 0.003%, quantitative isolate recovery in treated animals was compared with that of untreated controls. A dose response was observed for all five susceptible strains. The two strains that were most sensitive to amphotericin B in vitro also were the most susceptible in vivo. At each dose level there was a two- to eightfold reduction in isolate recovery among highly susceptible strains compared with less susceptible strains (P less than 0.05). The five resistant strains remained so even when the 0.3% concentration was used. Among strains of C. albicans susceptible to amphotericin B, there appeared to be a variation in degree of susceptibility in vivo that correlated with the minimum inhibitory concentration.
0 Communities
1 Members
0 Resources
13 MeSH Terms